Related Experiment Video

Updated: Jun 25, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Visualizing the cause of gray matter atrophy in multiple sclerosis

Nancy D Richert, Eduard Kraft, Olaf Stüve

    Archives of Neurology
    |February 11, 2009
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
    06:48

    Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images

    Published on: January 7, 2019

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
    08:51

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

    Published on: February 19, 2021

    Related Experiment Videos

    Last Updated: Jun 25, 2026

    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
    09:41

    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

    Published on: July 19, 2019

    Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
    06:48

    Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images

    Published on: January 7, 2019

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
    08:51

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

    Published on: February 19, 2021

    Related Concept Videos

    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

    Articles linked to this work by shared authors, journal, and citation graph.

    Induced pluripotent stem cell treatment for microglia replacement in progressive MS.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2026

    NSAID use is associated with lower dementia and Alzheimer's disease prevalence and slower cognitive decline: A retrospective longitudinal analysis of the NACC cohort.

    medRxiv : the preprint server for health sciences·2026

    Utility of Multi-Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from Pseudoexacerbation.

    Neurology and therapy·2026

    Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort.

    Frontiers in immunology·2026

    Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple Sclerosis.

    Neurology(R) neuroimmunology & neuroinflammation·2026

    Vedolizumab and the gut-CNS axis in multiple sclerosis: considering T cell licensing pathways.

    Therapeutic advances in neurological disorders·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us